1. Home
  2. AHMA vs ARMP Comparison

AHMA vs ARMP Comparison

Compare AHMA & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AHMA

Ambitions Enterprise Management Co. L.L.C Class A Ordinary Shares

N/A

Current Price

$5.85

Market Cap

150.1M

ML Signal

N/A

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

N/A

Current Price

$11.81

Market Cap

296.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AHMA
ARMP
Founded
2007
N/A
Country
United Arab Emirates
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
150.1M
296.7M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
AHMA
ARMP
Price
$5.85
$11.81
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$15.00
AVG Volume (30 Days)
34.5K
45.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
53.40
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$180.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.25
$0.90
52 Week High
$39.50
$13.75

Technical Indicators

Market Signals
Indicator
AHMA
ARMP
Relative Strength Index (RSI) 35.95 64.18
Support Level $5.70 $5.14
Resistance Level $9.75 $12.23
Average True Range (ATR) 0.54 1.06
MACD 0.24 0.04
Stochastic Oscillator 10.15 82.58

Price Performance

Historical Comparison
AHMA
ARMP

About AHMA Ambitions Enterprise Management Co. L.L.C Class A Ordinary Shares

Ambitions Enterprise Management Co LLC, through its subsidiaries in the UAE, operates as a tour operator, travel agency, and event planning and management services provider. It provides two lines of services, namely, MICE management, a comprehensive coordination and organization of events, and one-stop tourism, a comprehensive travel product that is designed to provide tourists with all the necessary components of a trip in a single and convenient package, which typically include transportation, accommodations, meals, and guided tours or activities.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: